Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Population pharmacokinetics and pharmacodynamics of nelfinavir and its active metabolite M8 in HIV-1-infected children.

Crommentuyn KM, Scherpbier HJ, Kuijpers TW, Mathôt RA, Huitema AD, Beijnen JH.

Pediatr Infect Dis J. 2006 Jun;25(6):538-43.

PMID:
16732153
2.

Pharmacokinetics and pharmacodynamics of saquinavir in pediatric patients with human immunodeficiency virus infection.

Grub S, Delora P, Lüdin E, Duff F, Fletcher CV, Brundage RC, Kline MW, Calles NR, Schwarzwald H, Jorga K.

Clin Pharmacol Ther. 2002 Mar;71(3):122-30. Review.

PMID:
11907486
3.

Updated clinical pharmacologic considerations for HIV-1 protease inhibitors.

Anderson PL, Fletcher CV.

Curr HIV/AIDS Rep. 2004 Apr;1(1):33-9. Review.

PMID:
16091221
4.

Pharmacokinetics and pharmacodynamics of drug interactions involving HIV-1 protease inhibitors.

Jackson A, Taylor S, Boffito M.

AIDS Rev. 2004 Oct-Dec;6(4):208-17. Review.

PMID:
15700619
5.

Pharmacokinetic studies in children with cancer.

Groninger E, Proost JH, de Graaf SS.

Crit Rev Oncol Hematol. 2004 Dec;52(3):173-97. Review.

PMID:
15582785
6.

Clinical pharmacokinetics and pharmacodynamics of anticancer drugs in children.

Rodman JH, Relling MV, Stewart CF, Synold TW, McLeod H, Kearns C, Stute N, Crom WR, Evans WE.

Semin Oncol. 1993 Feb;20(1):18-29. Review.

PMID:
8475406
7.

Pharmacokinetic-pharmacodynamic modelling: history and perspectives.

Csajka C, Verotta D.

J Pharmacokinet Pharmacodyn. 2006 Jun;33(3):227-79. Epub 2006 Jan 11. Review.

PMID:
16404503
8.

Pharmacokinetic-pharmacodynamic relationships for benzodiazepines.

Laurijssens BE, Greenblatt DJ.

Clin Pharmacokinet. 1996 Jan;30(1):52-76. Review.

PMID:
8846627
9.

Pharmacokinetics in children: history, considerations, and applications.

Suggs DM.

J Am Acad Nurse Pract. 2000 Jun;12(6):236-9. Review.

PMID:
11930447
10.
11.

Understanding dosing: children are small adults, neonates are immature children.

Anderson BJ, Holford NH.

Arch Dis Child. 2013 Sep;98(9):737-44. doi: 10.1136/archdischild-2013-303720. Epub 2013 Jul 5. Review.

PMID:
23832061
12.

Pharmacokinetic optimization of antiretroviral therapy in children and adolescents.

Neely MN, Rakhmanina NY.

Clin Pharmacokinet. 2011 Mar;50(3):143-89. doi: 10.2165/11539260-000000000-00000. Review.

PMID:
21294595
13.

Population pharmacokinetics.

Ludden TM.

J Clin Pharmacol. 1988 Dec;28(12):1059-63. Review.

PMID:
3072349
14.

[Response variability in pharmacotherapy].

Cadórniga Carro R.

An R Acad Nac Med (Madr). 1999;116(1):149-71; discussion 171-2. Review. Spanish.

PMID:
10554395
15.

A pharmacokinetic perspective on medicament noncompliance.

Levy G.

Clin Pharmacol Ther. 1993 Sep;54(3):242-4. Review. No abstract available.

PMID:
8375119
16.

Problems in pharmacokinetic investigations in patients with HIV infection.

Unadkat JD, Agosti JM.

Clin Pharmacokinet. 1990 Sep;19(3):172-6. Review. No abstract available.

PMID:
2203578

Supplemental Content

Support Center